| # | Drug | Count |
|---|---|---|
| 0 | SODIUM OXYBATE | 47 |
| 1 | OMALIZUMAB | 35 |
| 2 | ADALIMUMAB | 29 |
| 3 | ERGOCALCIFEROL | 29 |
| 4 | HUMAN IMMUNOGLOBULIN G | 28 |
| 5 | GABAPENTIN | 26 |
| 6 | CLONAZEPAM | 25 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 25 |
| 8 | DUPILUMAB | 24 |
| 9 | ALBUTEROL SULFATE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROMOLYN SODIUM | 5 | 0.0014 |
| 1 | HUMAN IMMUNOGLOBULIN G | 28 | 0.0013 |
| 2 | ASFOTASE ALFA | 13 | 0.0013 |
| 3 | ERGOCALCIFEROL | 29 | 0.0010 |
| 4 | PONATINIB HYDROCHLORIDE | 5 | 0.0010 |
| 5 | PYRIDOSTIGMINE BROMIDE | 7 | 0.0009 |
| 6 | SODIUM OXYBATE | 47 | 0.0008 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 9 | 0.0007 |
| 8 | IVABRADINE | 5 | 0.0007 |
| 9 | BOSUTINIB | 6 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 55 |
| 1 | Corticosteroid [EPC] | 43 |
| 2 | Benzodiazepine [EPC] | 40 |
| 3 | Anti-IgE [EPC] | 35 |
| 4 | Vitamin C [EPC] | 31 |
| 5 | Human Immunoglobulin G [EPC] | 30 |
| 6 | Provitamin D2 Compound [EPC] | 29 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 24 |
| 9 | Catecholamine [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 2 | Human Immunoglobulin G [EPC] | 30 | 0.0014 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 13 | 0.0013 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 7 | 0.0010 |
| 6 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 7 | Somatostatin Analog [EPC] | 6 | 0.0009 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 3 | 0.0007 |
| 9 | Endoglycosidase [EPC] | 1 | 0.0005 |